It's an exciting time to be in genomics.
As I sit writing this from the heart of the year-old BioData Innovation Centre (BIC) at the world-leading Wellcome Genome Campus, there is a definite energy emanating from the various start-ups that have..
The Telegraph today reported that drug industry leaders are calling for the UK to put more investment into the ‘global commercial opportunity’ in genomics.
Gene expression is tightly regulated and controls the development and maintenance of cells within all organisms. Misregulation of genes can cause adverse effects, for example in humans this could contribute to the initiation and progression of a..
Eagle has a proven history of discovering actionable biomarkers in complex molecular datasets. Our success is based on a flexible, disciplined and collaborative approach that puts the researcher’s scientific priorities first. This is..
In recent years science has moved rapidly from identifying the first genes involved in cancer (1) to characterising entire cancer genomes (2). These advances herald our understanding the molecular basis of this entire..
William Spooner, Eagle Genomics' CSO, will be facilitating a round-table discussion at the upcoming BioData World Congress (21-22 October 2015) to be held at the Wellcome Trust Genome Campus, Cambridge, UK.
In a recent post our CTO Will Spooner discussed the benefits of the 'blackboard' approach to NGS software pipelines and how this has been used by the developers of eHive at the European Bioinformatics Institute (EBI). The eHive tool is used there..